Parkway Pantai
A Singapore-based private healthcare group operating hospitals, clinics, medical centres and diagnostic facilities across Asia and the Middle East.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Parkway Pantai Limited is a Singapore-based private healthcare company and a wholly owned subsidiary of IHH Healthcare. It is positioned within the IHH group as a major hospital and healthcare-services platform, with operations extending across Singapore, Malaysia, India, Brunei, Hong Kong, Mainland China, Vietnam and the United Arab Emirates. Its network includes acute-care hospitals, specialist and outpatient facilities, primary-care clinics, radiology services, laboratories and other ancillary healthcare operations. The group is associated with a substantial private-hospital presence in Southeast Asia. Its Singapore network includes four private hospitals and a wider set of medical centres and supporting facilities. Notable hospitals associated with the Parkway and Pantai businesses include Mount Elizabeth Hospital, Gleneagles Hospital and Pantai-branded hospitals in Malaysia. The wider regional network also includes Jerudong Park Medical Centre in Brunei and hospital operations in Malaysia and India. Across the reported network, Parkway Pantai has more than 4,000 licensed beds and more than 60 medical centres, clinics and ancillary healthcare facilities. Parkway Pantai's business scope extends beyond inpatient treatment. Parkway Shenton operates a large general-practice network in Singapore, while ParkwayHealth Radiology and ParkwayHealth Laboratory provide diagnostic imaging and laboratory services. The group also supports specialist care, outpatient consultations, surgery, emergency services, health screening and other hospital-based treatments. Some facilities participate in international healthcare accreditation programmes, although accreditation status varies across the network. The company developed from the Parkway and Pantai healthcare businesses and became part of the IHH Healthcare structure. Parkway Holdings Limited began operating as a subsidiary of Parkway Pantai in August 2010. IHH Healthcare is headquartered in Kuala Lumpur and its largest shareholder is Khazanah Nasional, the Malaysian state investment agency. IHH also owns the International Medical University, creating a broader healthcare ecosystem alongside its hospital operations. Parkway Pantai serves both domestic patients and international patients. Its hospitals work with health-tourism providers to support cross-border medical travel, particularly for specialist and complex care. The brand's market proposition combines hospital infrastructure, specialist expertise, primary care and diagnostics with an international, premium-oriented service model. The company is therefore best understood not as a single hospital brand but as a multi-country healthcare operating platform within IHH Healthcare. In July 2017, reports stated that Parkway Pantai issued a US$2 billion multicurrency bond to refinance debt. Beyond that financing event, publicly available reference material does not establish a separate standalone listing, current executive roster or independently reported financial statements for Parkway Pantai. Its corporate identity and strategic direction are closely linked to its parent, IHH Healthcare.
History
Parkway Pantai emerged from the combination of the Parkway and Pantai healthcare businesses and operates as part of the IHH Healthcare group. The company is based in Singapore, while its parent, IHH Healthcare, is based in Kuala Lumpur. The Parkway and Pantai names represent established private-healthcare operations in Singapore and Malaysia, and their associated assets later formed part of a broader multinational healthcare platform. A documented structural milestone occurred in August 2010, when Parkway Holdings Limited began operating as a subsidiary of Parkway Pantai Limited. This placed the Parkway hospital and healthcare businesses within the Parkway Pantai corporate structure. Parkway Pantai subsequently operated under IHH Healthcare, which is also associated with the International Medical University and has Khazanah Nasional as its largest shareholder. The company's operating model expanded beyond individual hospitals. In Singapore, the network includes four private hospitals together with medical centres, clinics and ancillary facilities. Parkway Pantai's wider portfolio includes regional hospitals in Malaysia, India and Brunei, including Jerudong Park Medical Centre, as well as operations and facilities connected with Hong Kong, Mainland China, Vietnam and the United Arab Emirates. The group has reported more than 4,000 licensed beds in aggregate and more than 60 medical centres, clinics and ancillary healthcare facilities across parts of its network. Parkway Pantai's healthcare platform includes hospital treatment, specialist medicine, outpatient care, primary care and diagnostics. Parkway Shenton forms part of its Singapore general-practice network. ParkwayHealth Radiology and ParkwayHealth Laboratory provide imaging and laboratory services, allowing the group to offer supporting diagnostics alongside hospital treatment. Accreditation is not uniform across all facilities: some hospitals are subject to international healthcare accreditation while others are not. The group also participates in the regional medical-tourism market. Health-tourism providers work with Parkway Pantai hospitals to develop international-patient services, linking the group's specialist facilities with patients travelling for treatment. This cross-border orientation is consistent with the group's geographic footprint and premium private-healthcare positioning. In July 2017, reports indicated that Parkway Pantai issued a US$2 billion multicurrency bond to refinance its debts. The financing transaction illustrates the scale of the group and its use of capital-market funding, but publicly available reference material does not provide a complete standalone financial history. The available sources also do not establish a definitive founding year, founder or current executive list for Parkway Pantai itself. The company remains best characterized as an IHH Healthcare-owned hospital and healthcare-services platform rather than an independently listed corporation.
- 2017
Multicurrency bond issued for debt refinancing
[1]Reports stated that Parkway Pantai issued a US$2 billion multicurrency bond to refinance debt.
- 2010
Parkway Holdings becomes a Parkway Pantai subsidiary
[1]Parkway Holdings Limited began operating as a subsidiary of Parkway Pantai Limited in August 2010, placing the Parkway healthcare business within the group's corporate structure.
Products and positioning
A large, premium-oriented private healthcare network serving domestic and international patients through hospitals, specialist services, primary care and diagnostics.
Hospital care
Private hospitals
Parkway Pantai operates a regional network of private hospitals, including four hospitals in Singapore and additional hospitals in Malaysia, India and Brunei. These facilities provide inpatient care, specialist consultations, surgery, emergency services and other hospital-based treatments. The network includes internationally recognized Parkway and Pantai facilities, although the available reference material does not provide a complete hospital-by-hospital service catalogue.
Primary care
Parkway Shenton
Parkway Shenton is part of Parkway Pantai's Singapore healthcare network and operates general-practice services. It extends the group beyond hospital care by providing community-based primary-care access and referrals into specialist and hospital services where appropriate.
Diagnostic imaging
ParkwayHealth Radiology
ParkwayHealth Radiology is the group's radiology service provider in Singapore. It supports diagnostic imaging needs associated with outpatient, specialist and hospital care, forming part of Parkway Pantai's integrated healthcare-services model.
Laboratory diagnostics
ParkwayHealth Laboratory
ParkwayHealth Laboratory provides laboratory services in Singapore and complements the group's hospitals, clinics and physicians. Its role is to supply diagnostic testing and related laboratory support for patients receiving care across the network.
International healthcare
International-patient and medical-tourism services
Parkway Pantai's hospitals work with health-tourism providers to develop services for patients travelling across borders for treatment. This offering connects the group's specialist hospitals and regional facilities with international patients seeking private medical care.
Brand decisions
2017
Debt refinancing through a multicurrency bondOtherBackground
Reports described Parkway Pantai as refinancing its debt through a large multicurrency bond issue.
Action taken
The company reportedly issued a US$2 billion multicurrency bond in July 2017.
Aftermath
The available reference material does not state the subsequent allocation of proceeds, changes in leverage or longer-term financial outcome.
Bond issuance. US$2 billion multicurrency bond issued (July 2017)
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/parkway-pantai · Editorial policy · How profiles are compiled